BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 10472963)

  • 21. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glaucoma progression detection with frequency doubling technology (FDT) compared to standard automated perimetry (SAP) in the Groningen Longitudinal Glaucoma Study.
    Wesselink C; Jansonius NM
    Ophthalmic Physiol Opt; 2017 Sep; 37(5):594-601. PubMed ID: 28836391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of frequency-doubling perimetry with retinal nerve fiber layer thickness and optic disc size in ocular hypertensives and glaucoma suspects.
    Kaushik S; Pandav SS; Ichhpujani P; Gupta A
    J Glaucoma; 2011 Aug; 20(6):366-70. PubMed ID: 20717056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humphrey matrix frequency doubling perimetry for detection of visual-field defects in open-angle glaucoma.
    Clement CI; Goldberg I; Healey PR; Graham S
    Br J Ophthalmol; 2009 May; 93(5):582-8. PubMed ID: 18669543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The distribution of visual field defects per quadrant in standard automated perimetry as compared to frequency doubling technology perimetry.
    Zein WM; Bashshur ZF; Jaafar RF; Noureddin BN
    Int Ophthalmol; 2010 Dec; 30(6):683-9. PubMed ID: 20924646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Test-retest variability in glaucoma patients tested with C-20-1 screening-mode frequency doubling technology perimetry.
    Brush MB; Chen PP
    J Glaucoma; 2004 Aug; 13(4):273-7. PubMed ID: 15226654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agreement between frequency doubling perimetry and static perimetry in eyes with high tension glaucoma and normal tension glaucoma.
    Kogure S; Toda Y; Crabb D; Kashiwagi K; Fitzke FW; Tsukahara S
    Br J Ophthalmol; 2003 May; 87(5):604-8. PubMed ID: 12714404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between frequency doubling technology perimetry and temporal frequency characteristics in early glaucoma.
    Jy-Haw Yu J; Kiyosawa M; Nemoto N; Momose K; Mori H; Mochizuki M
    Doc Ophthalmol; 2003 Sep; 107(2):93-9. PubMed ID: 14661898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity and specificity of frequency-doubling technology, tendency-oriented perimetry, and Humphrey Swedish interactive threshold algorithm-fast perimetry in a glaucoma practice.
    Wadood AC; Azuara-Blanco A; Aspinall P; Taguri A; King AJ
    Am J Ophthalmol; 2002 Mar; 133(3):327-32. PubMed ID: 11860968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glaucoma diagnostics.
    Geimer SA
    Acta Ophthalmol; 2013 Feb; 91 Thesis 1():1-32. PubMed ID: 23384049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency-doubling perimetry in patients following penetrating keratoplasty.
    Nguyen NX; Horn FK; Seitz B; Cursiefen C; Küchle M
    Cornea; 2004 Jul; 23(5):433-8. PubMed ID: 15220725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of frequency doubling technology perimetry using the Humphrey Matrix 24-2 threshold strategy.
    Spry PG; Hussin HM; Sparrow JM
    Br J Ophthalmol; 2005 Aug; 89(8):1031-5. PubMed ID: 16024860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Learning effects among perimetric novices in frequency doubling technology perimetry.
    Joson PJ; Kamantigue ME; Chen PP
    Ophthalmology; 2002 Apr; 109(4):757-60. PubMed ID: 11927436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal age-related sensitivity loss for a variety of visual functions throughout the visual field.
    Gardiner SK; Johnson CA; Spry PG
    Optom Vis Sci; 2006 Jul; 83(7):438-43. PubMed ID: 16840869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of frequency doubling perimetry in detecting neuro-ophthalmic visual field defects.
    Thomas D; Thomas R; Muliyil JP; George R
    Am J Ophthalmol; 2001 Jun; 131(6):734-41. PubMed ID: 11384569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for glaucomatous visual field loss with frequency-doubling perimetry.
    Johnson CA; Samuels SJ
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):413-25. PubMed ID: 9040475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Threshold Automated Perimetry of the Full Visual Field in Patients With Glaucoma With Mild Visual Loss.
    Wall M; Lee EJ; Wanzek RJ; Zamba KD; Turpin A; Chong LX; Marin-Franch I
    J Glaucoma; 2019 Nov; 28(11):997-1005. PubMed ID: 31567907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of optic neuropathy in glaucomatous eyes with normal standard visual fields using a test battery of short-wavelength automated perimetry and pattern electroretinography.
    Bayer AU; Maag KP; Erb C
    Ophthalmology; 2002 Jul; 109(7):1350-61. PubMed ID: 12093662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH; Hutchison DM; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.
    Haymes SA; Hutchison DM; McCormick TA; Varma DK; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):547-54. PubMed ID: 15671281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.